Pagedf1dfofdf822
Test Bank for Basic and Clinical Pharmacology 14th Edition by
df df df df df df df df df
Bertram G. Katzung
df df df df
Chapters 1 - 66 Complete
df df df df
, Pagedf2dfofdf822
Table of Contents
df df
1.dfIntroduction:dfThedfNaturedfofdfDrugsdf&dfDrugdfDevelopmentdf&dfRegulation
2.dfDrugdfReceptorsdf&dfPharmacodynamics
3.dfPharmacokineticsdf&dfPharmacodynamics:dfRationaldfDosingdf&dfthedfTimedfCoursedfofdfDrugdfAction
4.dfDrugdfBiotransformation
5.dfPharmacogenomics
6.dfIntroductiondftodfAutonomicdfPharmacology
7.dfCholinoceptor-Activatingdf&dfCholinesterase-InhibitingdfDrugs
8.dfCholinoceptor-BlockingdfDrugs
9.dfAdrenoceptordfAgonistsdf&dfSympathomimeticdfDrugs
10.dfAdrenoceptordfAntagonistdfDrugs
11.dfAntihypertensivedfAgents
12.dfVasodilatorsdf&dfthedfTreatmentdfofdfAnginadfPectoris
13.dfDrugsdfUseddfindfHeartdfFailure
14.dfAgentsdfUseddfindfCardiacdfArrhythmias
15.dfDiureticdfAgents
16.dfHistamine,dfSerotonin,df&dfthedfErgotdfAlkaloids
17.dfVasoactivedfPeptides
18.dfThedfEicosanoids:dfProstaglandins,dfThromboxanes,dfLeukotrienes,df&dfRelateddfCompounds
19.dfNitricdfOxide
20.dfDrugsdfUseddfindfAsthma
21.dfIntroductiondftodfthedfPharmacologydfofdfCNSdfDrugs
22.dfSedative-HypnoticdfDrugs
23.dfThedfAlcohols
24.dfAntiseizuredfDrugs
25.dfGeneraldfAnesthetics
26.dfLocaldfAnesthetics
27.dfSkeletaldfMuscledfRelaxants
28.dfPharmacologicdfManagementdfofdfParkinsonismdf&dfOtherdfMovementdfDisorders
29.dfAntipsychoticdfAgentsdf&dfLithium
30.dfAntidepressantdfAgents
31.dfOpioiddfAgonistsdf&dfAntagonists
32.dfDrugsdfofdfAbuse
33.dfAgentsdfUseddfindfCytopenias;dfHematopoieticdfGrowthdfFactors
34.dfDrugsdfUseddfindfDisordersdfofdfCoagulation
35.dfAgentsdfUseddfindfDyslipidemia
36.dfNonsteroidaldfAnti-InflammatorydfDrugs,dfDisease-
, Pagedf3dfofdf822
ModifyingdfAntirheumaticdfDrugs,dfNonopioiddfAnalgesics,df&dfDrugsdfUseddfindfGout
37.dfHypothalamicdf&dfPituitarydfHormones
38.dfThyroiddf&dfAntithyroiddfDrugs
39.dfAdrenocorticosteroidsdf&dfAdrenocorticaldfAntagonists
40.dfThedfGonadaldfHormonesdf&dfInhibitors
41.dfPancreaticdfHormonesdf&dfAntidiabeticdfDrugs
42.dfAgentsdfThatdfAffectdfBonedfMineraldfHomeostasis
43.dfBeta-Lactamdf&dfOtherdfCelldfWall-df&dfMembrane-ActivedfAntibiotics
44.dfTetracyclines,dfMacrolides,dfClindamycin,dfChloramphenicol,dfStreptogramins,df&dfOxazolidinones
45.dfAminoglycosidesdf&dfSpectinomycin
46.dfSulfonamides,dfTrimethoprim,df&dfQuinolones
47.dfAntimycobacterialdfDrugs
48.dfAntifungaldfAgents
49.dfAntiviraldfAgents
50.dfMiscellaneousdfAntimicrobialdfAgents;dfDisinfectants,dfAntiseptics,df&dfSterilants
51.dfClinicaldfUsedfofdfAntimicrobialdfAgents
52.dfAntiprotozoaldfDrugs
53.dfClinicaldfPharmacologydfofdfthedfAntihelminthicdfDrugs
54.dfCancerdfChemotherapy
55.dfImmunopharmacology
56.dfIntroductiondftodfToxicology:dfOccupationaldf&dfEnvironmental
57.dfHeavydfMetaldfIntoxicationdf&dfChelators
58.dfManagementdfofdfthedfPoisoneddfPatient
59.dfSpecialdfAspectsdfofdfPerinataldf&dfPediatricdfPharmacology
60.dfSpecialdfAspectsdfofdfGeriatricdfPharmacology
61.dfDermatologicdfPharmacology
62.dfDrugsdfUseddfindfthedfTreatmentdfofdfGastrointestinaldfDiseases
63.dfTherapeuticdf&dfToxicdfPotentialdfofdfOver-the-CounterdfAgents
64.dfDietarydfSupplementsdf&dfHerbaldfMedications
65.dfRationaldfPrescribingdf&dfPrescriptiondfWriting
66.dfImportantdfDrugdfInteractionsdf&dfTheirdfMechanismsdf\
, Pagedf4dfofdf822
Chapter 1. Introduction: The Nature of Drugs & Drug Development & Regulation
df df df df df df df df df df df
1.
Adfnursedfworkingdfindfradiologydfadministersdfiodinedftodfadfpatientdfwhodfisdfha
vingdfadfcomputeddftomographydf(CT)dfscan.dfThedfnursedfworkingdfondfthedfoncol
ogydfunitdfadministersdfchemotherapydftodfpatientsdfwhodfhavedfcancer.dfAtdfthedf
PublicdfHealthdfDepartment,dfadfnursedfadministersdfadfmeasles-mumps-
rubelladf(MMR)dfvaccinedftofdadf14-month-
olddfchilddfasdfadfroutinedfimmunization.dfWhichdfbranchdfofdfpharmacologydfbestd
fdescribesdfthedfactionsdfofdfalldfthreed f nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacologydfisdfthedfstudydfofdfthedfbiologicdfeffectsdfofdfchemicals.dfNursesdfar
edfinvolveddfwithdfclinicaldfpharmacologydfordfpharmacotherapeutics,dfwhichdfisdf
adfbranchdfofdfpharmacologydfthatdfdealsdfwithdfthedfusesdfofdfdrugsdftodftreat,dfpre
vent,dfanddfdiagnosedfdisease.dfThedfradiologydfnursedfisdfadministeringdfadfdrugdft
odfhelpdfdiagnosedfadfdisease.dfThedfoncologydfnursedfisdfadministeringdfadfdrugdfto
dfhelpdftreatdfafd
disease.dfPharmacoeconomicsdfincludesdfanydfcostsdfinvolveddfindf
drugd f therapy.
Pharmacodynamicsdfinvolvesdfhowdfadfdrugdfaffectsdfthedfbodydf
andfdpharmacokineticsdfisdfhowdfthedfbodydfactsdfondfthedfbody.
2.
Adfphysiciandfhasdfordereddfintramusculardf(IM)dfinjectionsdfofdfmorphine,dfadf
narcotic,dfeverydf4dfhoursdfasdfneededdffordfpaindfindfadfmotordfvehicledfaccidentdfv
ictim.fdThedfnursedfisdfawaredfthisdfdrugdfhasdfadfhighdfabusedfpotential.dfUnderdfwh
atdfcategoryfdwoulddfmorphinedfbedfclassified?
A) ScheduledfI
Test Bank for Basic and Clinical Pharmacology 14th Edition by
df df df df df df df df df
Bertram G. Katzung
df df df df
Chapters 1 - 66 Complete
df df df df
, Pagedf2dfofdf822
Table of Contents
df df
1.dfIntroduction:dfThedfNaturedfofdfDrugsdf&dfDrugdfDevelopmentdf&dfRegulation
2.dfDrugdfReceptorsdf&dfPharmacodynamics
3.dfPharmacokineticsdf&dfPharmacodynamics:dfRationaldfDosingdf&dfthedfTimedfCoursedfofdfDrugdfAction
4.dfDrugdfBiotransformation
5.dfPharmacogenomics
6.dfIntroductiondftodfAutonomicdfPharmacology
7.dfCholinoceptor-Activatingdf&dfCholinesterase-InhibitingdfDrugs
8.dfCholinoceptor-BlockingdfDrugs
9.dfAdrenoceptordfAgonistsdf&dfSympathomimeticdfDrugs
10.dfAdrenoceptordfAntagonistdfDrugs
11.dfAntihypertensivedfAgents
12.dfVasodilatorsdf&dfthedfTreatmentdfofdfAnginadfPectoris
13.dfDrugsdfUseddfindfHeartdfFailure
14.dfAgentsdfUseddfindfCardiacdfArrhythmias
15.dfDiureticdfAgents
16.dfHistamine,dfSerotonin,df&dfthedfErgotdfAlkaloids
17.dfVasoactivedfPeptides
18.dfThedfEicosanoids:dfProstaglandins,dfThromboxanes,dfLeukotrienes,df&dfRelateddfCompounds
19.dfNitricdfOxide
20.dfDrugsdfUseddfindfAsthma
21.dfIntroductiondftodfthedfPharmacologydfofdfCNSdfDrugs
22.dfSedative-HypnoticdfDrugs
23.dfThedfAlcohols
24.dfAntiseizuredfDrugs
25.dfGeneraldfAnesthetics
26.dfLocaldfAnesthetics
27.dfSkeletaldfMuscledfRelaxants
28.dfPharmacologicdfManagementdfofdfParkinsonismdf&dfOtherdfMovementdfDisorders
29.dfAntipsychoticdfAgentsdf&dfLithium
30.dfAntidepressantdfAgents
31.dfOpioiddfAgonistsdf&dfAntagonists
32.dfDrugsdfofdfAbuse
33.dfAgentsdfUseddfindfCytopenias;dfHematopoieticdfGrowthdfFactors
34.dfDrugsdfUseddfindfDisordersdfofdfCoagulation
35.dfAgentsdfUseddfindfDyslipidemia
36.dfNonsteroidaldfAnti-InflammatorydfDrugs,dfDisease-
, Pagedf3dfofdf822
ModifyingdfAntirheumaticdfDrugs,dfNonopioiddfAnalgesics,df&dfDrugsdfUseddfindfGout
37.dfHypothalamicdf&dfPituitarydfHormones
38.dfThyroiddf&dfAntithyroiddfDrugs
39.dfAdrenocorticosteroidsdf&dfAdrenocorticaldfAntagonists
40.dfThedfGonadaldfHormonesdf&dfInhibitors
41.dfPancreaticdfHormonesdf&dfAntidiabeticdfDrugs
42.dfAgentsdfThatdfAffectdfBonedfMineraldfHomeostasis
43.dfBeta-Lactamdf&dfOtherdfCelldfWall-df&dfMembrane-ActivedfAntibiotics
44.dfTetracyclines,dfMacrolides,dfClindamycin,dfChloramphenicol,dfStreptogramins,df&dfOxazolidinones
45.dfAminoglycosidesdf&dfSpectinomycin
46.dfSulfonamides,dfTrimethoprim,df&dfQuinolones
47.dfAntimycobacterialdfDrugs
48.dfAntifungaldfAgents
49.dfAntiviraldfAgents
50.dfMiscellaneousdfAntimicrobialdfAgents;dfDisinfectants,dfAntiseptics,df&dfSterilants
51.dfClinicaldfUsedfofdfAntimicrobialdfAgents
52.dfAntiprotozoaldfDrugs
53.dfClinicaldfPharmacologydfofdfthedfAntihelminthicdfDrugs
54.dfCancerdfChemotherapy
55.dfImmunopharmacology
56.dfIntroductiondftodfToxicology:dfOccupationaldf&dfEnvironmental
57.dfHeavydfMetaldfIntoxicationdf&dfChelators
58.dfManagementdfofdfthedfPoisoneddfPatient
59.dfSpecialdfAspectsdfofdfPerinataldf&dfPediatricdfPharmacology
60.dfSpecialdfAspectsdfofdfGeriatricdfPharmacology
61.dfDermatologicdfPharmacology
62.dfDrugsdfUseddfindfthedfTreatmentdfofdfGastrointestinaldfDiseases
63.dfTherapeuticdf&dfToxicdfPotentialdfofdfOver-the-CounterdfAgents
64.dfDietarydfSupplementsdf&dfHerbaldfMedications
65.dfRationaldfPrescribingdf&dfPrescriptiondfWriting
66.dfImportantdfDrugdfInteractionsdf&dfTheirdfMechanismsdf\
, Pagedf4dfofdf822
Chapter 1. Introduction: The Nature of Drugs & Drug Development & Regulation
df df df df df df df df df df df
1.
Adfnursedfworkingdfindfradiologydfadministersdfiodinedftodfadfpatientdfwhodfisdfha
vingdfadfcomputeddftomographydf(CT)dfscan.dfThedfnursedfworkingdfondfthedfoncol
ogydfunitdfadministersdfchemotherapydftodfpatientsdfwhodfhavedfcancer.dfAtdfthedf
PublicdfHealthdfDepartment,dfadfnursedfadministersdfadfmeasles-mumps-
rubelladf(MMR)dfvaccinedftofdadf14-month-
olddfchilddfasdfadfroutinedfimmunization.dfWhichdfbranchdfofdfpharmacologydfbestd
fdescribesdfthedfactionsdfofdfalldfthreed f nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacologydfisdfthedfstudydfofdfthedfbiologicdfeffectsdfofdfchemicals.dfNursesdfar
edfinvolveddfwithdfclinicaldfpharmacologydfordfpharmacotherapeutics,dfwhichdfisdf
adfbranchdfofdfpharmacologydfthatdfdealsdfwithdfthedfusesdfofdfdrugsdftodftreat,dfpre
vent,dfanddfdiagnosedfdisease.dfThedfradiologydfnursedfisdfadministeringdfadfdrugdft
odfhelpdfdiagnosedfadfdisease.dfThedfoncologydfnursedfisdfadministeringdfadfdrugdfto
dfhelpdftreatdfafd
disease.dfPharmacoeconomicsdfincludesdfanydfcostsdfinvolveddfindf
drugd f therapy.
Pharmacodynamicsdfinvolvesdfhowdfadfdrugdfaffectsdfthedfbodydf
andfdpharmacokineticsdfisdfhowdfthedfbodydfactsdfondfthedfbody.
2.
Adfphysiciandfhasdfordereddfintramusculardf(IM)dfinjectionsdfofdfmorphine,dfadf
narcotic,dfeverydf4dfhoursdfasdfneededdffordfpaindfindfadfmotordfvehicledfaccidentdfv
ictim.fdThedfnursedfisdfawaredfthisdfdrugdfhasdfadfhighdfabusedfpotential.dfUnderdfwh
atdfcategoryfdwoulddfmorphinedfbedfclassified?
A) ScheduledfI
